Citations

Mayo Clinic

Clear

359 citation(s) found for "Qin, Ye".

OR21-1 Adiposity and Diabetes Genetic Risk Modulates Causal Effects of BMI and Type 2 Diabetes on NAFLD: A Wax-and-Wane Pattern
Wang, Yuying , Chen, Yi , Xia, Fangzhen , Han, Bing , Li, Qin , Jensen, Michael D. , Lu, Yingli , Wang, Ningjian , Wan, Heng , Chen, Chi , Zhang, Wen

Journal of the Endocrine Society | May 10, 2019 | Volume: 3 | Issue: Supplement_1 | Pages: No page available

10.1210/js.2019-or21-1 Get It

A comparison of the natural history of oxaliplatin- and paclitaxel-induced neuropathy (NCCTG N08C1, N08CB/Alliance).
Ruddy, Kathryn J. , Pachman, Dierdre, Qin, Rui , Seisler, Drew K., Puttabasavaiah, Suneetha, Novotny, Paul J. , Ta, Lauren E., Beutler, Andreas S. , Wagner‐Johnston, Nina D. , Grothey, Axel, Dakhil, Shaker R. , Loprinzi, Charles L. , Lavoie Smith, Ellen M , Staff, Nathan P.

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 9564-9564

10.1200/jco.2015.33.15_suppl.9564 Get It

CALGB 70604 (Alliance): A randomized phase III study of standard dosing vs. longer interval dosing of zoledronic acid in metastatic cancer.
Himelstein, Andrew L., Qin, Rui , Novotny, Paul J. , Seisler, Drew K., Khatcheressian, James, Roberts, John D. , Grubbs, Stephen S., Weckstein, Douglas, Loprinzi, Charles L. , O’Connor, Tracey L. , Shapiro, Charles L.

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 9501-9501

10.1200/jco.2015.33.15_suppl.9501 Get It

Venlafaxine to prevent oxaliplatin-induced neuropathy?: A pilot randomized placebo-controlled trial.
Zimmerman, Collin, Atherton, Pamela J. , Pachman, Deirdre R. , Seisler, Drew K., Wagner‐Johnston, Nina D. , Dakhil, Shaker R. , Lafky, Jacqueline M., Qin, Rui , Loprinzi, Charles L. , Grothey, Axel

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e20734-e20734

10.1200/jco.2015.33.15_suppl.e20734 Get It

Twin randomized studies of daratumumab (DARA; D) plus standard of care (lenalidomide/dexamethasone or bortezomib/dexamethasone [DRd or DVd]) versus Rd or Vd alone in relapsed or refractory multiple myeloma (MM): 54767414MMY3003 (Pollux) and 54767414MMY3004
Palumbo, Antonio , Reece, Donna , Sonneveld, Pieter , Spencer, Andrew , Chanan‐Khan, Asher , Goldschmidt, Hartmut , Yeh, Howard, Schecter, Jordan M. , Qin, Xiang , Amin, Himal, Guckert, Mary, Ahmadi, Tahamtan , Dimopoulos, Meletios Α. , Orlowski, Robert Z.

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: TPS8609-TPS8609

10.1200/jco.2015.33.15_suppl.tps8609 Get It

Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain
Leenstra, James L. , Loprinzi, Charles L. , Rine, G.P., Curtis, Amarinthia, Singh, Anurag K. , Martenson, James A., Novotny, Paul J. , Tan, Angelina D., Qin, Rui , Reiter, Paul L. , Miller, Robert C. , Ko, Stephen J. , Sio, Terence T. , Le‐Rademacher, Jennifer

JAMA | April 16, 2019 | Volume: 321 | Issue: 15 | Pages: 1481

10.1001/jama.2019.3504 | PMID 30990550 Get It

A molecular and clinico-pathological model for predicting abiraterone acetate/prednisone (AA/P) efficacy in metastatic castrate resistant prostate cancer (mCRPC).
Qin, Rui , Sicotte, Hugues , Carlson, Rachel E. , Tan, Winston , Jiménez, Rafael E. , Wang, Liewei , Eckel‐Passow, Jeanette E. , Costello, Brian A. , Pitot, Henry C., Dronca, Roxana , Wu, Kevin J. , Moynihan, Timothy J. , Atwell, Thomas D. , McMenomy, Brendan P., Kohli, Manish , Wang, Liguo , Quevedo, Fernando , Ho, Thai H. , Bryce, Alan H. , Dehm, Scott M.

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 5056-5056

10.1200/jco.2015.33.15_suppl.5056 Get It

Quality of life analysis of NCCTG N0877 (Alliance): Phase II trial of either dasatinib or placebo combined with standard chemoradiotherapy for newly diagnosed glioblastoma multiforme (GBM).
Qin, Rui , Tan, Angelina D., Sloan, Jeff A. , Lesser, Glenn J. , Anderson, S. Keith , Johnson, Derek R. , Laack, Nadia N.

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e17715-e17715

10.1200/jco.2015.33.15_suppl.e17715 Get It

Effects of pazopanib therapy on mean corpuscular volume in patients enrolled in MC1112: Analysis of correlation with time to disease progression in solid tumors.
Burton, Jill K., Qin, Rui , Erlichman, Charles , Harris, Pamela Jo , Bible, Keith C. , Kumar, Aditi , Suman, Vera J. , Haluska, Paul

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e13596-e13596

10.1200/jco.2015.33.15_suppl.e13596 Get It

Efficacy of siltuximab in patients with previously treated multicentric Castleman’s disease (MCD).
Munshi, Nikhil C. , Ke, Xiaoyan , Simpson, David , Lechowicz, Mary Jo , Bandekar, Rajesh, Qin, Xiang , Qi, Ming , Vermeulen, Jessica, Rhee, Frits van , Wong, Raymond , Fosså, Alexander , Dispenzieri, Angela , Kuruvilla, John , Vermeulen, Jessica, Casper, Corey

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 8514-8514

10.1200/jco.2014.32.15_suppl.8514 Get It